Loading company…
Matrixome manufactures and sells research products for regenerative medicine, including laminin-based cell culture substrates.
Founded in 2015 and based in Osaka, Japan, Matrixome manufactures and sells products developed from its research. Its products include laminin E8 fragment substrates for culturing cardiomyocytes and inducing stem cell differentiation into vascular endothelial cells. The company works with Osaka University research and Nippi Co., Ltd., which manufactures its products.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in